MBNL proteins in health, disease, and therapeutic applications. [PDF]
Musiała-Kierklo N +4 more
europepmc +1 more source
Current biomarker development in myotonic dystrophies. [PDF]
Larsen M +4 more
europepmc +1 more source
Identification of Splicing Regulatory Activity of ATXN1 and Its Associated Domains. [PDF]
Ohki A +5 more
europepmc +1 more source
Lipoprotein lipase deficiency: heterozygotes match homozygotes in severity. [PDF]
Szczęśniak D +7 more
europepmc +1 more source
Comparative Analysis of Splicing Alterations in Three Muscular Dystrophies. [PDF]
Todorow V +3 more
europepmc +1 more source
Next generation sequencing panel as an effective approach to genetic testing in patients with a highly variable phenotype of neuromuscular disorders. [PDF]
Radziwonik-Fraczyk W +9 more
europepmc +1 more source
Utility of prenatal trio whole-exome sequencing and methylation-specific multiplex ligation-dependent probe amplification in the evaluation of fetal growth restriction. [PDF]
Chen Y +5 more
europepmc +1 more source
Myotonic Dystrophy type 2 unmasked by physical activity resumption following COVID-19 lockdown: case discussion and review of the literature. [PDF]
Lucchiari S +6 more
europepmc +1 more source
CLCN5 inhibits tumorigenesis and fatty acid accumulation in clear cell renal cell carcinoma by regulating Enoyl CoA hydratase and 3-Hydroxyacyl CoA dehydrogenase. [PDF]
Yu T +6 more
europepmc +1 more source
Real-world evaluation of gnomAD variant co-occurrence information for haplotype phasing in autosomal recessive disorders. [PDF]
Kim J, Kim GH, Min S, Seol CA, Seo EJ.
europepmc +1 more source

